Malin Lundström

Malin Lundström is the Director of Site Management & Monitoring at AstraZeneca, a position held since 2023. With 21 years of experience in clinical trials, Malin has previously worked in various roles including Clinical Team Manager at PPD Scandinavia AB and Manager of Clinical Operations at IQVIA. Malin's extensive knowledge of clinical trials and GCP stems from previous positions at pharmaceutical companies and CROs, including roles at Novartis Sverige AB and PPD Scandinavia AB. Malin holds a Master of Science in Pharmaceutical from Uppsala University, completed in 1998.